Skip to Content

Ganirelix Dosage

Medically reviewed on December 15, 2017.

Applies to the following strengths: 250 mcg/0.5 mL

Usual Adult Dose for:

Usual Adult Dose for Gonadotropin Inhibition

To prevent leuteinizing hormone (LH) surges during controlled ovarian hyperstimulation:

0.25 mg subcutaneously once a day. Ganirelix is most conveniently administered in the abdomen around the navel or upper thigh. Generally, exogenous follicle stimulating hormone (FSH) is initiated on day 2 or 3 of a natural menstrual cycle. Ganirelix is administered beginning day 7 or 8 (day 6 of FSH treatment). Ganirelix therapy is continued until adequate follicular maturation is noted, at which time human chorionic gonadotropin (hGC) is administered.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.